Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
Novavax COVID-19 Vaccine Trial
Project summary:
A phase 3, randomised, observer-blinded, placebo-controlled trial to evaluate the efficacy and safety of a Sars-Cov-2 recombinant spike protein nanoparticle vaccine (Sars-Cov-2 RS) with Matrix-M1TN adjuvant in adult participants 18-84 years of age in the United Kingdom.